All Stories

  1. Smooth Muscle Progenitor Cells Preserve the Erectile Function by Reducing Corporal Smooth Muscle Cell Apoptosis after Bilateral Cavernous Nerve Crush Injury in Rats
  2. Videourodynamic factors predictive of successful onabotulinumtoxinA urethral sphincter injection for neurogenic or non-neurogenic detrusor underactivity
  3. Significant intravesical prostatic protrusion and prostatic calcification predict unfavorable outcomes of medical treatment for male lower urinary tract symptoms
  4. 5α-Reductase inhibitor is less effective in men with small prostate volume and low serum prostatic specific antigen level
  5. Effect of Ginkgo biloba Extract (EGb-761) on Recovery of Erectile Dysfunction in Bilateral Cavernous Nerve Injury Rat Model
  6. Different number of intravesical onabotulinumtoxinA injections for patients with refractory detrusor overactivity do not affect treatment outcome: A prospective randomized comparative study
  7. MP89-17 DIFFERENT INJECTION NUMBER OF INTRAVESICAL ONABOTULINUMTOXINA INJECTION FOR OVERACTIVE BLADDER SYNDROME DOES NOT AFFECT TREATMENT OUTCOME - A PROSPECTIVE RANDOMIZED COMPARATIVE STUDY
  8. Clinical guidelines for male lower urinary tract symptoms associated with non-neurogenic overactive bladder
  9. Perspectives on mirabegron in the treatment of overactive bladder syndrome: A new beta-3 adrenoceptor agonist
  10. How to choose first-line treatment for men with predominant storage lower urinary tract symptoms: a prospective randomised comparative study
  11. Clinical guidelines for the diagnosis and management of neurogenic lower urinary tract dysfunction
  12. Efficacy and Safety of Intravesical OnabotulinumtoxinA Injection on Elderly Patients with Chronic Central Nervous System Lesions and Overactive Bladder
  13. Use of the International Prostate Symptom Score voiding-to-storage subscore ratio in assessing lower urinary tract symptoms
  14. Taiwanese Continence Society clinical guidelines for diagnosis and management of neurogenic lower urinary tract dysfunction
  15. Progression of Lower Urinary Tract Symptoms After Discontinuation of 1 Medication From 2-Year Combined Alpha-blocker and 5-Alpha–reductase Inhibitor Therapy for Benign Prostatic Hyperplasia in Men – A Randomized Multicenter Study
  16. Diabetes mellitus does not affect the efficacy and safety of intravesical onabotulinumtoxina injection in patients with refractory detrusor overactivity
  17. Body mass index and buttock circumference are independent predictors of disintegration failure in extracorporeal shock wave lithotripsy for ureteral calculi
  18. First-line antimuscarinic monotherapy is safe and effective in men with predominant storage symptoms of the lower urinary tract
  19. Predictors of Successful First-line Antimuscarinic Monotherapy in Men With Enlarged Prostate and Predominant Storage Symptoms
  20. Increased Risk of Large Post-Void Residual Urine and Decreased Long-Term Success Rate After Intravesical OnabotulinumtoxinA Injection for Refractory Idiopathic Detrusor Overactivity
  21. International Prostatic Symptom Score — Voiding/Storage Subscore Ratio in Association with Total Prostatic Volume and Maximum Flow Rate Is Diagnostic of Bladder Outlet-Related Lower Urinary Tract Dysfunction in Men with Lower Urinary Tract Symptoms
  22. Urodynamic characteristics of voiding dysfunction in patients with a cerebrovascular accident
  23. Urodynamic characteristics of lower urinary tract dysfunction in patients with Parkinson's disease
  24. Androgens inhibit tumor necrosis factor-α-induced cell adhesion and promote tube formation of human coronary artery endothelial cells
  25. Change in intraoperative rectal temperature influencing erectile dysfunction following transurethral resection of the prostate
  26. Reply by the Authors
  27. Low serum sex hormone-binding globulin: Marker of inflammation?
  28. High Classification of Chronic Heart Failure Increases Risk of Overactive Bladder Syndrome and Lower Urinary Tract Symptoms
  29. Outcome of Surgery for Primary Hyperaldosteronism
  30. Reply
  31. Lower urinary tract symptoms and erectile dysfunction
  32. Serum C-reactive Protein Levels are Associated With Residual Urgency Symptoms in Patients With Benign Prostatic Hyperplasia After Medical Treatment
  33. Testosterone and sex hormone-binding globulin have significant association with metabolic syndrome in Taiwanese men
  34. Serum Testosterone Levels Significantly Correlate With Nocturia in Men Aged 40-79 Years
  35. Increased Risk for Cancer Following Erectile Dysfunction: A Nationwide Population-Based Follow-Up Study
  36. The efficacy of additive tolterodine extended release for 1-year in older men with storage symptoms and clinical benign proastatic hyperplasia
  37. Significant association between serum dihydrotestosterone level and prostate volume among Taiwanese men aged 40–79 years
  38. Urgency severity scale could predict urodynamic detrusor overactivity in patients with overactive bladder syndrome
  39. Retroperitoneoscopic laparo-endoscopic single-site radical nephrectomy (RLESS-RN): initial experience with a homemade port
  40. Anti-angiogenic effects and mechanism of prazosin
  41. Adverse Events of Intravesical Botulinum Toxin A Injections for Idiopathic Detrusor Overactivity: Risk Factors and Influence on Treatment Outcome
  42. Novel Inanimate Training Model for Urethrovesical Anastomosis in Laparoscopic Radical Prostatectomy
  43. Emphysematous cystitis
  44. Laparoscopic simultaneous bilateral partial and total adrenalectomy: a longer follow-up
  45. Urethro-subcutaneous fistula and bilateral abscesses of the thighs
  46. Lymphovascular invasion predicts poor outcome of urothelial carcinoma of renal pelvis after nephroureterectomy
  47. L-Shaped Cross-Fused Kidney With Stone
  48. Primary obstructive megaureter with ruptured kidney
  49. Bilateral seminal vesicle abscesses
  50. Erectile dysfunction, testosterone deficiency, metabolic syndrome and prostatic disease in Taiwan
  51. Re: Busby JE, Brown GA, Matin SF. Comparing Lymphadenectomy During Radical Nephroureterectomy: Open Versus Laparoscopic (Urology 71:413-416, 2008)
  52. Emphysematous Pyelonephritis with Acute Renal Failure
  53. Rebuttal
  54. Laparoscopic Adrenalectomy Using Needlescopic Instruments for Adrenal Tumors Less Than 5cm in 112 Cases
  55. Purple urine bag syndrome with acidic urine
  56. Laparoscopic Adrenalectomy for a 6-cm Left Adrenal Pheochromocytoma with Needlescopic Instruments
  57. Reply from Authors re: Andrei Nadu. Is Smaller Actually Better? Needlescopic Surgery — A Step Towards (Virtually) Incisionless Surgery. Eur Urol 2008;54:493–5
  58. Urothelial Carcinoma in Kidney Transplant Recipients: Conversion From Calcineurin Inhibitor to Proliferation Signal Inhibitor?
  59. Laparoscopic partial adrenalectomy for aldosterone-producing adenomas with needlescopic instruments
  60. Laparoscopic Adrenalectomy for Potentially Malignant Adrenal Tumors Greater than 5 Centimeters
  61. Laryngeal kaposi???s sarcoma in a renal-transplant recipient
  62. CLIPLESS LAPAROSCOPIC ADRENALECTOMY WITH NEEDLESCOPIC INSTRUMENTS
  63. CLIPLESS LAPAROSCOPIC ADRENALECTOMY WITH NEEDLESCOPIC INSTRUMENTS